No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing--remitting multiple sclerosis patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples